Cipla Uncorks Peptide Injectables Pipeline, Eyes Partnering For Monkeypox

 
• By Anju Ghangurde

Cipla readies scale up in peptide injectables with five filings in the US and gears for upcoming high value launches for generic versions of Advair, Revlimid and Abraxane. The company is also exploring partnering opportunities for monkeypox.

Cipla Outlines Peptide Pipeline Plans • Source: Shutterstock

More from Business

More from Scrip